A study of pediatric patients with hepatoblastoma led by researchers at Children’s Hospital Los Angeles (CHLA) suggests an opportunity to reduce chemotherapy in up to 65 percent of patients, which could lead to a decrease in the incidence of adverse effects. Their findings were published online this week in the British Journal of Surgery.
Obese youths with acute lymphoblastic leukemia (ALL) are known to have worse outcomes than their lean counterparts. To find out why, investigators at Children’s Hospital Los Angeles studied patients who were obese at the time of their diagnosis with ALL to determine if body mass index (BMI) impacted response to initial chemotherapy.
Pat Levitt, PhD, Simms/Mann Chair in Developmental Neurogenetics at Children's Hospital Los Angeles, has received a grant of nearly $1 million from Autism Speaks, the world’s leading autism science and advocacy organization. Funding will support research into the treatment of chronic constipation to improve behavioral symptoms associated with autism spectrum disorder (ASD).